CY1107586T1 - Θepαπεiα για τη δυσκοιλιoτητα - Google Patents
Θepαπεiα για τη δυσκοιλιoτηταInfo
- Publication number
- CY1107586T1 CY1107586T1 CY20071100396T CY071100396T CY1107586T1 CY 1107586 T1 CY1107586 T1 CY 1107586T1 CY 20071100396 T CY20071100396 T CY 20071100396T CY 071100396 T CY071100396 T CY 071100396T CY 1107586 T1 CY1107586 T1 CY 1107586T1
- Authority
- CY
- Cyprus
- Prior art keywords
- consideration
- prophylaxis
- treatment
- colchicine
- constipation
- Prior art date
Links
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 abstract 4
- 238000011321 prophylaxis Methods 0.000 abstract 3
- 238000011282 treatment Methods 0.000 abstract 3
- NBGAYCYFNGPNPV-UHFFFAOYSA-N 2-aminooxybenzoic acid Chemical class NOC1=CC=CC=C1C(O)=O NBGAYCYFNGPNPV-UHFFFAOYSA-N 0.000 abstract 2
- 206010010774 Constipation Diseases 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 2
- 229960001338 colchicine Drugs 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Παρέχεται φαρμακευτική σύνθεση για τη θεραπεία ή την προφύλαξη από τη δυσκοιλιότητα, με τη σύνθεση να περιλαμβάνει ή να αποτελείται από κολχικίνη και τουλάχιστον ένα παράγωγο αμινοσαλικυλικού οξέος. Η εφεύρεση παρέχει επίσης μέθοδο για τη θεραπεία ή την προφύλαξη από τη δυσκοιλιότητα σε θηλαστικό που έχει ανάγκη την εν λόγω θεραπεία ή προφύλαξη, περιλαμβανομένης της χορήγησης στο θηλαστικό αποτελεσματικής ποσότητας κολχικίνης και αποτελεσματικής ποσότητας τουλάχιστον ενός παραγώγου αμινοσαλικυλικού οξέος.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPO6653A AUPO665397A0 (en) | 1997-05-07 | 1997-05-07 | Novel therapy for constipation |
EP98918987A EP0980246B1 (en) | 1997-05-07 | 1998-05-07 | Therapy for constipation |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1107586T1 true CY1107586T1 (el) | 2013-03-13 |
Family
ID=3800945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20071100396T CY1107586T1 (el) | 1997-05-07 | 2007-03-20 | Θepαπεiα για τη δυσκοιλιoτητα |
Country Status (13)
Country | Link |
---|---|
US (1) | US6426338B1 (el) |
EP (1) | EP0980246B1 (el) |
AR (1) | AR012671A1 (el) |
AT (1) | ATE349216T1 (el) |
AU (1) | AUPO665397A0 (el) |
CA (1) | CA2289717C (el) |
CY (1) | CY1107586T1 (el) |
DE (1) | DE69836735T2 (el) |
DK (1) | DK0980246T3 (el) |
ES (1) | ES2279573T3 (el) |
PT (1) | PT980246E (el) |
WO (1) | WO1998050043A1 (el) |
ZA (1) | ZA983852B (el) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL154536A0 (en) | 2000-08-29 | 2003-09-17 | Nobex Corp | Immunoregulatory compounds and derivatives and methods of treating diseases therewith |
US6414016B1 (en) | 2000-09-05 | 2002-07-02 | Sucampo, A.G. | Anti-constipation composition |
US7186855B2 (en) * | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US8048917B2 (en) * | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US8048924B2 (en) | 2001-08-29 | 2011-11-01 | Biocon Limited | Methods and compositions employing 4-aminophenylacetic acid compounds |
AUPS088702A0 (en) * | 2002-03-04 | 2002-03-28 | Borody, Thomas Julius | Electrolyte purgative |
US7025745B2 (en) * | 2002-10-07 | 2006-04-11 | Advanced Cardiovascular Systems, Inc. | Method of making a catheter balloon using a tapered mandrel |
DE10257824B4 (de) * | 2002-12-10 | 2004-11-11 | Kochem, Hans-Günter, Dr. | Zusammensetzung zur Schmerzbehandlung, insbesondere zur Behandlung von Gelenkschmerzen |
US20050075395A1 (en) * | 2003-05-28 | 2005-04-07 | Gary Gordon | Continuous dosing regimen |
US20040242649A1 (en) * | 2003-05-29 | 2004-12-02 | Hagey Anne E. | Extended dosing regimen |
WO2004105794A2 (en) * | 2003-05-29 | 2004-12-09 | Abbott Laboratories | Continuous dosing regimen with abt-751 |
ATE554752T1 (de) | 2004-02-06 | 2012-05-15 | Pharmatel R & D Pty Ltd As Trustee For The Pharmatel R & D Trust | Verwendung von aminosalicylaten beim reizdarmsyndrom mit durchfall als vorherrschendem symptom |
US20050191371A1 (en) * | 2004-02-12 | 2005-09-01 | Rizo Andres M. | Medical composition |
JP5009152B2 (ja) * | 2004-05-28 | 2012-08-22 | サリックス ファーマシューティカルズ, インコーポレイテッド | 放射線誘発性腸炎の予防、処置、および回復 |
ES2565848T3 (es) | 2004-07-07 | 2016-04-07 | Biocon Limited | Síntesis de compuestos inmunorreguladores unidos por grupos azoicos |
US8921344B2 (en) * | 2006-11-03 | 2014-12-30 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
US7452872B2 (en) * | 2005-08-24 | 2008-11-18 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
EP2529729A1 (en) * | 2005-08-24 | 2012-12-05 | Salix Pharmaceuticals, Inc. | Balsalazide formulations and manufacture thereof |
AU2010312309B2 (en) | 2009-10-26 | 2016-10-06 | Thomas Julius Borody | Novel enteric combination therapy |
HRP20220751T1 (hr) | 2010-02-01 | 2022-09-02 | Rebiotix, Inc. | Bakterioterapija clostridium difficile kolitisa |
US8497256B2 (en) | 2010-04-26 | 2013-07-30 | Salix Pharmaceuticals, Ltd | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males |
JP6121334B2 (ja) | 2010-12-13 | 2017-04-26 | サリックス ファーマシューティカルズ,インコーポレイテッド | 胃および結腸製剤ならびにそれらを作製するための方法および使用するための方法 |
JP2015514715A (ja) * | 2012-03-30 | 2015-05-21 | タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド | コルヒチン製剤、その製造方法および使用方法 |
NZ704014A (en) | 2012-07-27 | 2017-10-27 | Redhill Biopharma Ltd | Formulations and methods of manufacturing formulations for use in colonic evacuation |
US10383901B2 (en) | 2013-06-05 | 2019-08-20 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
CA2914636C (en) | 2013-06-05 | 2021-04-06 | Rebiotix, Inc. | Microbiota restoration therapy (mrt), compositions and methods of manufacture |
US9511100B2 (en) | 2013-06-05 | 2016-12-06 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US9694039B2 (en) | 2013-06-05 | 2017-07-04 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US9782445B2 (en) | 2013-06-05 | 2017-10-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US9511099B2 (en) | 2013-06-05 | 2016-12-06 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US10799539B2 (en) | 2015-06-09 | 2020-10-13 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
US10828340B2 (en) | 2015-06-09 | 2020-11-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
IL281424B2 (en) | 2015-06-09 | 2023-10-01 | Rebiotix Inc | Microbiota restoration treatment preparations and production methods |
US10905726B2 (en) | 2015-06-09 | 2021-02-02 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3425441B2 (ja) * | 1990-10-22 | 2003-07-14 | ガストロ サービシイズ ピーティーワイ リミテッド | 非炎症性及び非感染性腸障害の処置 |
US5519014A (en) * | 1990-10-22 | 1996-05-21 | Borody; Thomas J. | Treatment of non-inflammatory and non-infectious bowel disorders |
-
1997
- 1997-05-07 AU AUPO6653A patent/AUPO665397A0/en not_active Abandoned
-
1998
- 1998-05-07 ZA ZA983852A patent/ZA983852B/xx unknown
- 1998-05-07 WO PCT/AU1998/000332 patent/WO1998050043A1/en active IP Right Grant
- 1998-05-07 PT PT98918987T patent/PT980246E/pt unknown
- 1998-05-07 EP EP98918987A patent/EP0980246B1/en not_active Expired - Lifetime
- 1998-05-07 DK DK98918987T patent/DK0980246T3/da active
- 1998-05-07 DE DE69836735T patent/DE69836735T2/de not_active Expired - Lifetime
- 1998-05-07 US US09/403,780 patent/US6426338B1/en not_active Expired - Lifetime
- 1998-05-07 ES ES98918987T patent/ES2279573T3/es not_active Expired - Lifetime
- 1998-05-07 CA CA002289717A patent/CA2289717C/en not_active Expired - Lifetime
- 1998-05-07 AT AT98918987T patent/ATE349216T1/de active
- 1998-05-07 AR ARP980102128A patent/AR012671A1/es unknown
-
2007
- 2007-03-20 CY CY20071100396T patent/CY1107586T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK0980246T3 (da) | 2007-05-07 |
AUPO665397A0 (en) | 1997-05-29 |
CA2289717A1 (en) | 1998-11-12 |
EP0980246B1 (en) | 2006-12-27 |
ATE349216T1 (de) | 2007-01-15 |
ZA983852B (en) | 1998-11-13 |
EP0980246A1 (en) | 2000-02-23 |
US6426338B1 (en) | 2002-07-30 |
ES2279573T3 (es) | 2007-08-16 |
EP0980246A4 (en) | 2004-04-14 |
DE69836735D1 (de) | 2007-02-08 |
CA2289717C (en) | 2009-02-03 |
WO1998050043A1 (en) | 1998-11-12 |
PT980246E (pt) | 2007-02-28 |
DE69836735T2 (de) | 2007-10-11 |
AR012671A1 (es) | 2000-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107586T1 (el) | Θepαπεiα για τη δυσκοιλιoτητα | |
CY1120313T1 (el) | Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει βιταμινη d και κορτικοστεοειδες | |
CY1114011T1 (el) | Φαρμακευτικη στοματικη δοσολογικη μορφη που περιλαμβανει ενα συνδυασμο ενος οπιοειδους αγωνιστη και ενος οπιοειδους ανταγωνιστη | |
CY1120625T1 (el) | Συνθεσεις και μεθοδοι χορηγησης φαρμακολογικων παραγοντων | |
CY1118317T1 (el) | Αντισωματα που ανοσοειδικως συνδεονται προς blys | |
CY1107615T1 (el) | Θεραπευτικοι συνδυασμοι αντιυπερτασικων και αντιαγγειογενετικων παραγοντων | |
CY1107314T1 (el) | Μεθοδος θεpαπευτικης αγωγης ασθενων προσβεβλημενων με σκληρυνση κατα πλακας χρησιμοποιωντας συναινετικη ιντepφepονη | |
TR199801315T2 (xx) | X sendromunun tedavisi i�in bir ppar-alpha ve ppar-gamma antagonistinin kullan�lmas�. | |
CY1105286T1 (el) | Ω-καρβοξυαρυλυποκατεστημενες διφαινυλουριες σαν αναστολεις της raf κινασης | |
CY1115916T1 (el) | Αντιβιοτικες συνθεσεις για θεραπεια του αυτιου | |
ATE417604T1 (de) | Matrix mit verzögerter freisetzung für hochdosierte unlösliche arzneistoffe | |
LU90987I2 (fr) | Copaxone et ses dérivés pharmaceutiquement acceptables | |
TR200001218T2 (tr) | İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler. | |
ES2067937T3 (es) | (+)-alfa-(2,3-dimetoxifenil)-1-(2-(4-fluorofenil)etil)-4-piperidinametanol. | |
ES2145774T3 (es) | Derivados de adenosina que tienen actividad agonista en a2. | |
CY1107103T1 (el) | Νεα παραγωγα νουκλεοζιτων με τροποποιημενη με καρβοξαμιδινη μονοκυκλικη βαση | |
EA200100572A1 (ru) | Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии | |
CY1106727T1 (el) | Ινδανυλ παραγωγα για την αντιμετωπιση ασθενειων αεραγωγων | |
ES2194536T3 (es) | Combinacion de duloxetina con farmacos antiinflamatorios no esteroideos. | |
GR1000465B (el) | Μεθοδος παρασκευης φαρμακευτικων συνθεσεων που περιεχουν ακετυλ d-καρνιτινη για την θεραπευτικη αγωγη του γλαυκωματος. | |
DK0902789T3 (da) | Androstenderivater | |
CY1111509T1 (el) | Ενωσεις με ιδιοτητες απελευθερωσης αυξητικης ορμονης | |
EE05054B1 (et) | 5-HT4 agonisti v?i antagonisti peroraalne ravimkoostis ja selle kasutamine meditsiinis | |
CY1106800T1 (el) | Μεθοδοι και συνθεσεις δια χρησιμοποιησεως μεταβολιτων τepφεναδινης εν συνδυασμω μετ’ αναστολεων λευκοτριενιου | |
SE9700934D0 (sv) | New formulation |